Vital Art and Science, LLC
The mVT™ Service detects early visual function changes related to retinal diseases, which can lead to sooner treatment and better patient outcomes.
- Stage Full Product Ready
- Industry Medical Devices and Equipment
- Location United States
- Currency USD
- Founded June 2006
- Employees 3
- Website myvisiontrack.com
Company Summary
Vital Art and Science, LLC has developed the first FDA cleared smartphone-based home vision function monitor for those afflicted with degenerative eye diseases such as diabetic retinopathy (DR) and Age Related Macular Degeneration (AMD). These afflict over 25M people in both the US and Europe today. The mVT™ Service is by prescription only and provides an easy and accurate way for patients to test their vision at home .
Team
-
Mike BartlettPresidentMike has over 30 years of experience in the electronics industry, including 5 years as Vice President of Texas Instrument during which time he was responsible for defining, developing and bringing to market hundreds of new electronic products.
-
Yi-Zhong WangChief Science OfficerYi-Zhong Wang, Ph.D., is a research scientist at Retina Foundation of Southwest and has over 20 years of research experience and skills in visual psychophysics, visual optics, computational modeling, computer programming, and development of new visual function tests. He has extensive experience working with seniors and patients with macular degeneration, diabetic retinopathy and Amblyopia.
Advisors
-
Tod Mongan, Mongan LawLawyerUnconfirmed
Montgomery Coscia Greilich LLPAccountantUnconfirmed
Previous Investors
-
National Eye Institute Phase I and Phase II SBIR GrantsUnconfirmed
Texas Emerging Technology FundUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.